Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/27/2785961/0/en/Turnstone-Biologics-to-Participate-in-the-Piper-Sandler-35th-Annual-Healthcare-Conference.html

SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) — Turnstone Biologics Corp. (“Turnstone”) (Nasdaq:TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today announced that Sammy Farah, M.B.A., Ph.D., Turnstone’s President and Chief Executive Officer, will participate in the Piper Sandler 35th Annual Healthcare Conference taking place November 28 – 30, 2023 in New York, NY.

Read more at globenewswire.com

Related news for (TSBX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.